4 papers in the library · 23 citations · publishing 2024
Clinical Case Reports September 1, 2024 David S Jevotovsky, Harman Chopra, Court Wing et al. 9 citations
Key Clinical Message Psilocybin shows promise as a treatment for CRPS, offering significant pain relief and functional improvement in a patient with refractory symptoms. This case highlights the need for further research into psilocybin's efficacy and optimal dosing for chronic pain management.
Regional Anesthesia & Pain Medicine August 5, 2024 Harman Chopra, Shravani Durbhakula, Alexander Shustorovich et al. 8 citations
Background/Importance Chronic pain affects many people globally, requiring alternative management strategies. Psilocybin is gaining attention for its potential in chronic pain management despite being classified as Schedule I. Objective This systematic review critically evaluates the evidence for psilocybin, a Schedule I substance, in the treatment of chronic pain. The exact purpose of the...
Clinical Case Reports May 28, 2024 Harman Chopra, Tim Furnish, Monica Verduzco-Gutierrez et al. 6 citations
Key Clinical Message Long‐COVID syndrome lacks effective holistic treatment options. We present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who obtained significant symptomatic relief after self‐medicating with psilocybin and MDMA. Abstract Long‐COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID‐19), lacks effective holistic...
April 2, 2024 Harman Chopra, Timothy Furnish, Monica Verduzco-Gutierrez et al.
IntroductionCoronavirus disease 2019 (COVID-19) is a highly contagious respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was first identified in Wuhan, China in December 2019 and has since spread